Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADCY2	"AC2, HBAC2, KIAA1060"	ENSG00000078295	"Adenylate cyclase 2"	Q08462	5	7396208-7830081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 35.9;skeletal muscle: 58.6"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 64.8;Horizontal cells: 190.7;Melanocytes: 38.8"	"Cancer enhanced"	"Detected in some"		"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"AF22: 9.0;NTERA-2: 6.9;SK-MEL-30: 7.5;SuSa: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031482, HPA038015, HPA038483"	Approved					NA	NA					"CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799"	"unprognostic (6.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.03e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.09e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.92e-3)"	1.8	3.3	16.8	1.3	14.5	1.2	2.8	6.6	35.9	4.9	1.9	6.7	0.7	1.9	3.9	1.7	4.0	4.1	2.1	1.2	14.5	9.4	1.2	1.1	1.3	1.1	12.8	10.0	5.1	1.9	1.0	5.1	1.8	11.3	6.2	1.6	2.0	1.5	5.1	58.6	6.3	1.8	4.3	12.5	1.2	2.6	3.6	5.4	0.0	1.1	5.1	1.2	1.9	2.1	0.9	0.4	1.5	0.4	0.3	0.6	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.5	6.4	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.4	0.1	0.4	0.2	0.4	0.5	0.3	0.3	0.1	0.9	0.4	0.6	1.5	0.3	0.3	0.4	0.2	0.0	16.8	14.5	6.6	22.5	14.5	9.4	12.8	10.0	11.3	5.4	3.0	2.4	0.0	0.6	5.3	28.6	1.6	0.0	9.4	4.5	0.0	64.8	0.6	0.0	0.5	2.5	1.4	0.0	0.0	0.4	0.2	2.8	7.3	1.1	0.0	0.2	190.7	12.1	0.6	0.0	2.1	4.0	2.6	38.8	0.0	0.1	1.9	2.0	0.3	1.8	0.2	4.0	0.0	1.0	1.2	0.7	4.1	0.7	0.0	0.2	0.8
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	21.4	0.0	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0
AMER2	"FAM123A, FLJ25477"	ENSG00000165566	"APC membrane recruitment protein 2"	Q8N7J2	13	25161684-25172288	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 57.0"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 86.8;Cone photoreceptor cells: 76.6;Horizontal cells: 144.6;Muller glia cells: 354.7;Rod photoreceptor cells: 96.7"	"Cancer enriched"	"Detected in single"	24	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"AF22: 5.9;SCLC-21H: 5.0;SuSa: 4.3;U-266/70: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039458	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039458: AB_10795677"	"unprognostic (1.69e-2)"	"unprognostic (4.13e-2)"		"unprognostic (7.43e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.00e-3)"		"unprognostic (5.00e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.90e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.34e-1)"		1.2	1.4	15.5	1.2	33.5	1.2	1.2	11.7	57.0	1.2	1.2	24.7	0.0	1.2	1.2	1.2	1.2	2.2	1.2	1.2	19.9	9.7	1.2	1.2	1.2	1.2	41.9	9.2	1.2	1.2	1.1	1.6	1.2	15.8	1.4	1.2	0.0	1.2	1.5	1.4	1.3	1.2	1.2	15.9	1.2	1.2	2.0	47.8	0.0	1.2	0.0	1.2	1.2	0.0	0.4	0.4	1.1	0.4	0.7	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.4	0.0	0.2	0.0	0.1	1.1	0.3	0.2	0.2	0.3	0.3	0.3	0.2	0.2	0.1	0.4	0.3	0.3	0.9	0.7	0.4	0.4	0.3	0.0	15.5	33.5	11.7	20.9	19.9	9.7	41.9	9.2	15.8	47.8	0.0	0.0	0.0	0.0	0.1	86.8	0.8	0.0	0.0	0.0	0.0	76.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.6	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	354.7	0.0	0.0	0.0	0.0	96.7	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 27.8;SuSa: 17.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0											0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	22.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 24.9;Ito cells: 12.9"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"AF22: 10.2;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0;SuSa: 4.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB025842	Approved					NA	NA					"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	8.4	2.1	26.1	3.8	14.2	0.0	3.3	3.8	21.0	1.2	2.3	30.8	0.0	1.8	1.6	0.0	1.8	1.2	5.7	7.2	24.8	9.3	2.5	8.0	3.5	4.0	17.3	10.2	1.2	1.4	1.9	1.5	40.4	32.8	1.2	2.8	0.2	1.7	0.8	5.8	3.0	1.7	4.7	63.8	44.1	1.5	1.2	18.2	0.1	3.1	0.6	1.8	3.8	1.5	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	26.1	14.2	3.8	16.3	24.8	9.3	17.3	10.2	32.8	18.2	0.0	0.0	0.0	0.0	2.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	12.9	0.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 40.1;testis: 29.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 317.4;Late spermatids: 661.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.0"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040665, HPA059846"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA040665: AB_10964282, HPA059846: "	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.1	0.1	0.1	5.3	0.2	0.0	0.3	0.1	0.1	0.3	17.6	0.1	0.1	11.5	0.1	0.4	0.4	0.2	7.7	0.1	0.1	0.1	0.3	0.3	1.3	1.6	0.1	0.1	0.4	11.2	0.0	0.1	0.1	0.1	1.6	13.3	0.1	0.8	0.1	0.1	0.1	40.1	0.1	0.1	0.9	7.8	29.8	0.1	4.1	0.1	0.3	1.2	2.5	0.2	0.9	0.0	0.1	0.2	0.0	3.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	5.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.9	1.4	0.7	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	3.0	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.9	0.0	2.6	0.3	0.3	0.4	2.5	2.7	4.5	1.8	0.0	0.1	0.0	0.3	317.4	0.3	31.5	0.0	6.6	0.0	0.4	3.1	0.0	0.0	0.2	0.0	6.4	0.0	0.0	661.8	5.2	0.0	0.0	6.4	42.7	0.0	3.3	17.5	3.5	0.0	0.7	6.5	0.0	5.2	2.7	0.4	0.1	0.0	26.4	7.8
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424487-93574730	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 10.8;kidney: 7.5"	"Group enriched"	"Detected in some"	14	"Early spermatids: 13.2;Late spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 10.8"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.1"	"Group enriched"	"Detected in some"	7	"MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;hypothalamus: 28.7"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported				NA	NA					"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.3	0.7	1.4	0.0	2.1	0.0	1.3	0.1	1.5	0.5	0.2	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.4	0.4	2.1	10.8	7.5	0.1	0.9	0.0	0.8	0.0	0.7	0.1	0.3	3.2	2.1	5.9	0.1	0.2	0.2	1.4	0.0	3.7	0.1	0.2	0.3	2.5	0.1	0.1	2.3	0.7	0.0	0.1	2.5	0.7	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.1	0.1	1.5	2.1	10.8	0.8	0.0	5.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 45.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 2.8;SuSa: 6.2"														"Intracellular and membrane"	NA	NA															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.1	0.0	2.8	0.0	0.3	0.2	0.2	0.3	0.0	0.3	0.6	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.2	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.8	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.3	0.4	0.3	0.0	14.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.3	10.2	0.0	0.0	7.0	0.0	35.2	3.3	5.0	0.0	0.0	0.0	0.0	0.6	165.5	2.6	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	2.7	0.0	20.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	117.5	0.0	0.0	0.3
CDH10		ENSG00000040731	"Cadherin 10"	Q9Y6N8	5	24487100-24644978	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 45.4"	"Cell type enhanced"	"Detected in single"	14	"Bipolar cells: 1.1"	"Group enriched"	"Detected in some"	7	"glioma: 5.3;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.8;HAP1: 5.6;hTERT-RPE1: 5.2;SuSa: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010651	Approved					NA	NA					"HPA010651: AB_1078370"	"unprognostic (4.31e-3)"			"unprognostic (2.77e-1)"	"unprognostic (1.88e-1)"			"unprognostic (3.66e-2)"		"unprognostic (4.48e-1)"	"unprognostic (6.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.59e-7)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-1)"		"unprognostic (8.74e-3)"	0.9	2.1	9.4	0.8	9.6	0.8	1.0	45.4	34.0	0.9	1.1	1.5	0.0	0.9	0.9	0.8	0.9	0.9	1.2	0.9	9.4	5.2	1.0	0.8	1.1	0.8	3.6	13.4	0.8	0.9	0.8	2.1	0.8	6.0	8.6	1.3	0.0	0.8	1.4	0.8	0.8	1.1	0.9	7.0	0.8	1.0	1.4	3.7	0.0	0.8	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	15.2	0.0	0.0	0.0	1.9	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.6	45.4	21.3	9.4	5.2	3.6	13.4	6.0	3.7	0.0	0.0	0.0	0.0	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
CDX1		ENSG00000113722	"Caudal type homeobox 1"	P47902	5	150166795-150184558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 83.7"	"Group enriched"	"Detected in some"	4	"Enterocytes: 265.6;Mucus-secreting cells: 170.9;Paneth cells: 276.3;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 125.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 11.4;SuSa: 6.9"	"Region enhanced"	"Detected in single"		"thalamus: 0.3"	"Not detected"	"Not detected"			HPA055196	Enhanced					NA	NA					"HPA055196: AB_2682734"	"unprognostic (2.50e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-7)"	"unprognostic (2.10e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.16e-3)"	0.2	0.1	0.1	18.6	0.2	0.0	0.2	0.1	0.2	0.2	63.6	0.2	0.1	19.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	38.5	0.1	0.1	0.1	0.1	0.2	83.7	1.5	0.1	0.1	0.1	0.9	0.1	0.5	0.1	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.3	0.0	11.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.1	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.9	0.0	0.0	276.3	1.4	0.0	0.0	0.0	2.4	3.0	8.9	0.3	0.1	0.0	217.4	0.0
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"skin 1: 5.3;testis: 3.3"	"Cell type enhanced"	"Detected in some"	22	"Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 2.0;SuSa: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.4	1.0	0.0	0.0	0.0	0.0
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Cell type enriched"	"Detected in some"	5	"Intestinal endocrine cells: 19.8"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1"									HPA041773	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	11.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell type enriched"	"Detected in some"	30	"Syncytiotrophoblasts: 71349.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"BEWO: 73.5;SuSa: 141.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	1223.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2346.5	0.1	1.5	0.0	0.0	567.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	71349.9	0.0	0.0	0.3
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 247.1;Collecting duct cells: 94.2;Distal tubular cells: 114.4;Ductal cells: 224.8;Exocrine glandular cells: 70.7;Melanocytes: 65.8;Muller glia cells: 75.5;Pancreatic endocrine cells: 89.7;Proximal tubular cells: 232.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.8"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 19.7;SuSa: 64.9"	"Low region specificity"	"Detected in all"							"CAB012969, HPA042348"	Enhanced					NA	NA					"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (4.75e-3)"	0.8	0.5	28.3	0.5	17.1	1.9	2.6	5.9	17.7	26.0	0.6	4.3	0.0	1.4	8.1	15.4	2.6	16.0	23.1	0.6	18.1	6.2	50.5	1.7	0.8	0.5	10.8	12.0	1.1	97.3	0.8	1.1	0.7	5.7	1.4	0.6	3.4	70.0	0.6	0.5	4.5	0.5	0.7	2.8	0.7	1.0	0.9	6.3	0.0	0.5	2.1	49.4	0.6	0.2	1.2	0.6	7.8	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.0	0.0	0.0	19.7	0.0	0.1	0.1	0.0	0.0	0.0	64.9	0.2	1.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.6	0.0	0.1	28.3	17.1	5.9	17.7	18.1	6.2	10.8	12.0	5.7	6.3	0.0	0.0	0.5	5.8	0.2	0.1	0.4	247.1	9.4	6.8	94.2	0.0	13.8	114.4	224.8	2.4	2.7	0.0	0.0	70.7	5.3	0.5	10.6	0.0	0.0	1.7	0.0	0.0	1.3	0.0	1.7	0.0	0.1	65.8	2.8	0.0	75.5	89.7	0.0	0.4	232.4	3.9	6.5	1.4	6.7	11.3	0.5	19.3	0.0	0.0	3.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 192.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4"	"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	1.2	12.2	0.0	9.1	28.2	0.0	0.0	0.0	0.0	0.0	0.0	192.3	0.2	0.1	0.0	0.0	4.4	0.0	0.0	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 9.5;testis: 4.8"	"Cell type enhanced"	"Detected in some"	28	"Cytotrophoblasts: 21.7;Ductal cells: 18.1;Extravillous trophoblasts: 119.4;Syncytiotrophoblasts: 36.8"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 25.8;ovarian cancer: 73.6;testis cancer: 112.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	6	"BEWO: 85.2;CACO-2: 23.1;NTERA-2: 78.4;SuSa: 61.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.50e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.66e-4)"	"unprognostic (1.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.78e-4)"	0.1	0.9	0.5	0.1	3.7	0.5	0.1	2.5	1.0	0.1	0.6	0.1	0.1	0.5	0.4	0.1	0.1	0.4	0.7	0.2	0.7	0.8	0.2	0.1	0.9	0.1	0.7	0.1	0.1	3.3	0.0	1.2	9.5	1.5	0.1	0.4	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.3	0.2	0.4	4.8	0.1	1.3	0.2	0.1	0.1	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	85.2	0.0	0.0	0.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	78.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	3.7	2.5	1.0	0.7	0.8	0.7	0.1	1.5	0.1	3.0	0.0	0.0	1.2	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	21.7	0.0	18.1	0.1	0.0	0.0	0.0	0.0	119.4	0.2	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.4	36.8	0.0	0.0	0.1
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092576-1404217	"Predicted membrane proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 41.4;thyroid gland: 18.9"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 1: 32.8"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016645	Uncertain					NA	NA		2100000			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0.0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3.0	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0.0	18.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	41.4	6.3	1.5	3.0	2.4	2.6	7.8	0.3	32.8	2.2	0.0	0.0	0.0	2.6	0.4	0.0	1.4	5.7	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3"									HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8	0.0	1.0	0.0	2.3	5.3	0.0	36.4	0.0	58.9	12.5	0.0	0.0	17.6	0.0	0.0	3.5	3.4	0.0	0.0	0.0	52.2	33.7	0.1	0.0	0.0	5.4	0.0	0.0	4.3	0.8	1.1	14.1	1.0	5.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	6.6	0.2	0.6	3.6	19.5	0.0	0.0	1.5
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 134.3"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 1.4;SuSa: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10000									"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	134.3	0.0	0.0	0.1
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246863-29254494	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5"	"Cell type enhanced"	"Detected in single"	33	"Syncytiotrophoblasts: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AF22: 6.8;BEWO: 8.8;SuSa: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022016	Supported					NA	NA					"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	1.5	0.3	1.4	0.0	0.0	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.4	0.0	0.7	0.1	0.0	0.0	6.8	0.1	0.0	0.0	8.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	1.4	0.4	0.4	0.7	0.1	0.8	1.0	0.3	0.1	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.3	0.0	2.8	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"placenta: 450.4"	"Group enriched"	"Detected in some"	22	"Extravillous trophoblasts: 439.3;Syncytiotrophoblasts: 913.5"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 12.0;SuSa: 18.9"									"CAB026374, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB026374: , HPA043715: AB_2678632"															"unprognostic (6.99e-2)"			2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	15.7	450.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	1.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	439.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	913.5	0.0	0.0	0.0
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"placenta: 246.2"	"Cell type enriched"	"Detected in some"	25	"Syncytiotrophoblasts: 230.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 10.2;SuSa: 15.3"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	246.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.4	0.0	0.0	0.0
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Group enriched"	"Detected in many"	9	"BEWO: 92.0;SuSa: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	5.9	1.8	2.0	5.3	0.1	0.0	92.0	0.0	0.0	1.3	1.0	12.1	5.9	0.0	0.5	0.0	8.8	11.4	9.8	7.2	1.9	0.0	1.3	0.2	0.6	1.8	0.0	0.0	0.8	0.0	2.4	0.3	0.3	0.1	0.4	1.7	0.2	0.0	2.3	2.2	0.1	0.0	12.2	12.0	1.7	0.0	4.4	0.1	1.8	0.7	0.5	0.9	6.0	2.1	2.1	118.9	3.8	0.7	0.0	0.3	6.0	0.0	0.6	1.2	3.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0	0.0	0.6	1.5	13.2	27.0	4.4	0.8	0.0	0.0	3.4	1.8	9.8	114.1	1.7	1.2	1.5	1.5	1.2	0.0	0.7	136.0	2.6	7.1	0.0	0.0	11.8	0.0	1.7	0.6	0.0	9.6	3.7	1.6	0.0	0.0	0.9	4.5	0.6	1.7	1.1	11.1	26.0	6.5	0.8	34.6	32.6	10.5	56.3	0.0	3.7	6.4
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 140.1"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 3051.6;Fibroblasts: 4090.0;Proximal tubular cells: 2046.8;Suprabasal keratinocytes: 1848.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;granulocytes: 1.1"	"Group enriched"	"Detected in some"	12	"HAP1: 17.2;hTCEpi: 22.8;RPTEC TERT1: 61.9;SuSa: 34.3;U-2 OS: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000				"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	59.5	0.9	19.4	25.8	14.9	0.2	44.1	0.6	20.7	40.7	30.0	1.5	4.5	38.8	6.8	26.1	16.7	5.2	3.8	11.2	10.8	4.6	79.2	10.3	1.7	13.9	6.3	9.3	2.1	2.8	0.3	25.4	30.5	7.6	7.0	34.3	14.3	44.2	3.7	17.2	140.1	59.2	8.6	1.0	15.1	18.7	5.1	2.4	1.5	10.0	30.2	22.9	12.7	17.0	0.2	3.2	1.1	0.3	0.3	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.8	0.0	1.1	0.0	17.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3	61.9	0.0	0.3	0.2	0.1	0.0	0.0	34.3	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.3	0.2	0.2	0.1	0.3	0.1	0.2	0.1	3.2	0.2	0.3	0.2	1.1	0.3	0.2	0.2	0.2	0.1	19.4	14.9	0.6	20.7	10.8	4.6	6.3	9.3	7.6	2.4	0.0	0.6	0.9	12.3	3051.6	249.2	2.0	0.0	0.0	0.0	268.7	0.0	28.7	477.5	0.0	0.6	4.8	0.0	0.0	0.0	24.5	4090.0	8.5	0.0	0.0	56.4	6.4	0.0	74.3	0.0	1.1	19.2	3.2	416.7	0.0	0.0	3.7	0.1	0.0	0.4	2046.8	14.0	0.0	20.0	0.5	4.1	1848.7	64.5	0.0	0.0	8.1
DMRT1	"CT154, DMT1"	ENSG00000137090	"Doublesex and mab-3 related transcription factor 1"	Q9Y5R6	9	841690-969090	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	81	"testis: 44.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.6;Spermatogonia: 103.9"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 8.5;SuSa: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027850	Enhanced					NA	NA					"HPA027850: AB_10600868"	"unprognostic (3.23e-1)"	"unprognostic (1.91e-1)"		"unprognostic (9.75e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.50e-1)"		"unprognostic (3.08e-1)"		"unprognostic (1.45e-1)"			"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.02e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.2	103.9	0.0	0.0	0.0	0.0	0.0
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.9;testis: 9.0"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7"									HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.5	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	8.7	0.5	0.1	0.1	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"	"Group enriched"	"Detected in some"	4	"HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.2	1.1	1.0	1.4	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	2.1	0.0	5.1	0.7	0.0	0.3
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 19.7"	"Cell type enriched"	"Detected in some"	31	"Syncytiotrophoblasts: 218.2"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 11.7;SuSa: 9.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	19.7		0.8	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044738-53051076	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	105	"placenta: 85.9"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 3.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 19.1;SuSa: 12.9;T-47d: 5.4"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 83.4"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	34	"BEWO: 43.6;SuSa: 13.9"															NA	NA						"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	83.4	0.2	0.2	0.1	0.2	0.4	0.2	0.4	0.4	0.2	0.2	0.3	0.3	0.5	10.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	2.2	0.8	0.1	0.2	0.0	0.1	0.2	0.3	0.2	0.0	0.3	43.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.7	0.0	0.2	0.2	0.3	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.6	0.0	13.9	0.1	0.2	0.1	0.0	0.8	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.4	2.2	0.2	0.8	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.6	0.0	0.1	0.0	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	3.0	1.9	0.0	0.5	0.7	2.2	0.2	0.0	9.4	2.3	0.0	0.0	179.3	0.0	0.0	28.9	0.1	0.0	0.0	0.0	79.7	2.8	0.2	2.3	0.0	23.6	0.0	0.0	0.0	1.0	5.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	1.4	0.0	0.0	0.5	0.4	1.8	714.1	0.0	0.0	0.5
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell type enhanced"	"Detected in single"	28	"Early spermatids: 2.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	64	"NTERA-2: 18.6;SuSa: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell type enriched"	"Detected in some"	13	"Distal tubular cells: 23.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Group enriched"	"Detected in some"	5	"MCF7: 4.0;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.9	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452656	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 11.6;retina: 15.7"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 3.2;Muller glia cells: 5.6;Syncytiotrophoblasts: 2.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 10.5"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BEWO: 24.7;SuSa: 33.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	11.6	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	1.9	0.5	0.9	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.4	0.2	0.3	0.4	0.4	0.3	0.2	0.7	0.4	0.6	1.5	0.9	0.5	0.5	0.2	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor rho1 subunit"	P24046	6	89177501-89231278	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"retina: 12.3;testis: 4.6"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 53.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"amygdala: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.4	0.0	2.2	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	1.0	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	6.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	53.4	0.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	3.8	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.4	2.9	1.9	0.0	1.7	1.5	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	15.4	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 36.0;SuSa: 67.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Uncertain		Uncertain	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	36.0	0.0	0.0	0.0	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.1	0.0	0.0	28.3	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	4.4	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"placenta: 1.3"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"NTERA-2: 4.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6		0.0	0.0	0.0	0.1	1.3		0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	13.7	0.0	0.0	0.0	0.0	0.6	0.0	2.7	4.5	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 66.0"	"Cell type enriched"	"Detected in many"	15	"Extravillous trophoblasts: 586.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 1.2;SuSa: 3.9"									CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000				"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.2	0.1	0.0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0.0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0.0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66.0	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	1.1	1.4	6.4	20.3	0.0	0.8	5.1	0.0	0.0	0.0	0.0	7.8	0.0	2.8	16.1	5.2	2.6	0.0	4.7	586.1	11.7	5.5	0.0	1.1	21.9	0.0	16.8	8.0	11.0	5.3	2.3	3.3	11.8	0.0	39.2	0.0	15.5	20.1	2.5	0.2	0.0	0.0	3.3	4.7	3.0	30.7	33.9	6.9	9.7	6.7
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531001	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.2;testis: 1.9;urinary bladder: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SuSa: 3.3;T-47d: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA044576	Uncertain					NA	NA					"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.1	0.1	2.2	0.8	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.1	0.1	1.5	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	17.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7	0.0	0.0	0.0	0.2	0.0	4.0	0.5	0.0	0.0	0.0	1.8	31.4	90.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	38.7	0.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.9	12.6	0.0	34.6	0.0	0.0	0.0
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	23.5	0.1	0.0	0.1	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.7	0.4	0.0	21.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9	0.0	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.2	0.0	0.0	0.0	7.3	14.9	0.8	0.0	0.0	0.5	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.3	0.0	3.5	0.2	0.3	0.0	1.7	0.0	0.1	0.0	4.6	0.0	0.6	0.0
KRTAP21-1	KAP21.1	ENSG00000187005	"Keratin associated protein 21-1"	Q3LI58	21	30754830-30755428	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"breast: 15.0;testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SK-MEL-30: 4.0;SuSa: 8.3"															NA	NA																							0.1	0.0	0.0	0.1	0.1	0.0	15.0	0.3	0.0	0.6	0.0			0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.2	0.0	0.1	0.0		0.9	0.0		0.2	1.2	0.0	1.7	0.0	0.1	0.4	0.1	0.0	4.0			0.0		0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	8.3	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194831-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.2;placenta: 34.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 8.1"	"Lineage enriched"	"Detected in single"	17	"monocytes: 8.1"	"Group enriched"	"Detected in some"	22	"NTERA-2: 68.4;SuSa: 53.8"									"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.6	0.8	0.2	18.2	0.4	0.0	0.7	0.4	0.2	1.6	6.9	0.0	0.3	0.1	0.3	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.4	0.2	3.1	1.6	0.2	0.1	1.3	0.3	0.0	0.4	34.0	0.7	2.4	1.6	1.5	0.7	0.1	0.6	0.3	0.6	0.5	0.2	2.9	0.4	8.5	0.0	0.4	2.4	0.1	0.1	1.6	1.3	0.4	0.3	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.7	0.0	6.0	15.4	0.0	0.5	0.3	2.5	0.3	0.0	10.7	13.6	0.0	5.9	82.1	0.0	0.0	0.3	0.7	0.2	0.0	0.3	20.0	2.1	0.3	1.1	0.0	6.6	3.2	10.2	0.0	0.8	0.4	1.7	2.0	0.0	0.0	4.4	0.3	0.4	0.9	17.3	0.0	3.9	0.0	0.9	0.7	13.2	0.1	23.6	1.9	0.6	0.2
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 16.3;Late spermatids: 27.4;Leydig cells: 16.7;Peritubular cells: 11.3"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 24.3;RPMI-8226: 26.2;SuSa: 15.6"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.3	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.3	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	27.4	16.7	0.0	1.7	0.0	0.1	0.3	0.0	0.0	11.3	0.0	0.1	0.0	1.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 361.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	11	"BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.3	0.1	7.1	0.2	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.3	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.2	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	361.5	0.0	0.0	0.1
LGALS16		ENSG00000249861	"Galectin 16"	A8MUM7	19	39655894-39660647	"Predicted intracellular proteins"	Apoptosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 14.2"	"Cell type enriched"	"Detected in some"	76	"Syncytiotrophoblasts: 852.8"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"BEWO: 5.5;SuSa: 16.1"															NA	NA																							0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.6	0.5	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	852.8	0.0	0.0	0.0
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Group enriched"	"Detected in some"	42	"Early spermatids: 24.2;Late spermatids: 49.8"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NTERA-2: 136.8;SuSa: 50.5"	"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.1	0.0	0.0	0.0	0.1
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.9"	"Cell type enriched"	"Detected in some"	16	"Muller glia cells: 199.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 5.9"	"Group enriched"	"Detected in some"	11	"RPTEC TERT1: 24.5;SuSa: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	1.0	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1.0	1.3	19.2	1.0	1.2	1.2	1.2	1.0	1.2	1.1	1.1	24.6	10.7	4.9	1.0	1.1	1.6	11.7	13.2	1.0	1.0	1.0	1.2	1.4	12.4	3.0	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13.0	0.0	6.5	0.0	1.0	1.0	0.2	5.9	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	1.2	0.1	0.0	0.0	5.9	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.8	0.0	0.0	0.0	1.4	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell type enriched"	"Detected in some"	1164	"Cardiomyocytes: 1233.0"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 5.7;SuSa: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046370, HPA051039"	Enhanced		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA046370: , HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB3	CT3.5	ENSG00000198798	"MAGE family member B3"	O15480	X	30230436-30237492	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 20.5;testis: 7.8"	"Cell type enhanced"	"Detected in some"	23	"Late spermatids: 1.1;Spermatocytes: 4.6;Spermatogonia: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SuSa: 4.3;U-266/70: 6.4"					"Not detected"	"Not detected"			HPA072203	Approved					NA	NA					"HPA072203: AB_2686492"															"unprognostic (3.34e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8			0.0		0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	6.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.1	0.0	0.0	0.0	0.0	0.0
MAGEL2	"NDNL1, nM15"	ENSG00000254585	"MAGE family member L2"	Q9UJ55	15	23643544-23647841	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	Repressor	"Autism spectrum disorder, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;pituitary gland: 13.0"	"Cell type enhanced"	"Detected in some"	12	"Horizontal cells: 3.2;Ito cells: 1.3;Leydig cells: 2.6;Muller glia cells: 1.9;Peritubular cells: 1.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 20.6;cerebral cortex: 6.4;hypothalamus: 19.4;pons and medulla: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.2;JURKAT: 2.7;NTERA-2: 4.4;SuSa: 5.4;U-2 OS: 2.3"	"Region enhanced"	"Detected in many"		"hypothalamus: 20.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.51e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.96e-9)"	"unprognostic (1.66e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-2)"	1.5	1.3	3.0	0.9	20.6	0.3	0.7	0.3	6.8	6.7	0.5	1.0	0.2	0.3	4.9	1.2	0.5	1.6	1.2	0.6	2.9	19.4	0.5	0.4	0.5	0.4	2.1	1.6	7.2	2.2	0.3	13.0	4.3	8.9	1.0	0.4	2.5	0.6	1.9	0.5	0.7	0.6	2.2	0.9	1.0	0.5	4.2	1.4	0.0	2.5	0.0	0.4	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.9	0.0	0.5	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	20.6	0.3	6.4	2.9	19.4	2.1	1.6	8.9	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.2	0.0	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIKIN		ENSG00000239642	"Meiotic kinetochore factor"	A0A087WXM9	5	131806993-131945698	"Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 16.3"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 16.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;non-classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SuSa: 2.3;U-2 OS: 5.9"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.21e-1)"				"unprognostic (2.30e-1)"			"unprognostic (2.64e-2)"		"unprognostic (5.27e-2)"	"unprognostic (4.31e-1)"		"unprognostic (4.64e-6)"	"unprognostic (2.38e-1)"		"unprognostic (3.81e-1)"		0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.5	0.0	3.2	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	2.7	0.4	0.5	0.1	0.1	1.5	0.5	1.0	0.0	0.0	0.0	3.2	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	4.1	0.0	0.0	0.0	0.0	0.0
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 99.1;Late spermatids: 74.0"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	11.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1	6.0	0.6	0.0	0.1	0.1	9.7	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.0	15.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.9	0.0	1.6	0.0	0.0	1.7	0.6	0.1	0.0	0.0	0.0	0.3
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29656981-29672372	"Disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 106.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 3.4;HEK 293: 2.1;SuSa: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021873	Enhanced					NA	NA					"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			1.9	1.7	22.1	1.7	35.1	1.7	1.7	3.1	30.0	1.7	1.9	79.5	0.0	1.7	1.7	1.7	1.7	1.7	1.7	1.7	40.2	19.6	2.0	1.7	1.8	1.7	49.2	17.1	2.0	1.7	1.7	0.0	1.8	39.8	1.8	2.1	0.0	1.7	2.2	1.7	1.7	2.0	1.7	106.4	1.7	1.7	2.0	46.4	0.0	1.7	0.0	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	22.1	35.1	3.1	30.0	40.2	19.6	49.2	17.1	39.8	46.4	0.0	0.6	0.0	0.3	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3
MS4A6E		ENSG00000166926	"Membrane spanning 4-domains A6E"	Q96DS6	11	60334831-60396596	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 28.2"	"Cell type enriched"	"Detected in some"	21	"Early spermatids: 1123.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.2"	"Group enriched"	"Detected in some"	7	"K-562: 2.1;SuSa: 4.2"									HPA076623			Approved	Vesicles		NA	NA			Vesicles		"HPA076623: AB_2686809"					"unprognostic (2.58e-1)"	"unprognostic (3.35e-1)"		"unprognostic (3.47e-1)"			"unprognostic (6.81e-3)"		"unprognostic (4.55e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"		2.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	28.2			0.0		0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1123.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	53.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	5.1	2.5	0.0	0.0	0.0	0.0	0.0
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell type enhanced"	"Detected in many"	21	"Distal tubular cells: 1414.2;Hepatocytes: 2756.5;Paneth cells: 1455.4;Proximal tubular cells: 6160.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"EFO-21: 5.5;SuSa: 14.2"															NA	NA						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	1.9	0.2	0.0	0.0	0.2	0.0	1.0	0.4	0.0	1.4	0.9	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5	0.0	0.0	30.6	1.2	10.9	0.0	2.0	17.8	0.0	1.2	507.7	0.0	2.4	1414.2	1.6	0.0	0.7	931.8	0.0	39.8	466.6	1.5	11.5	4.6	2756.5	16.3	0.0	42.0	27.6	30.2	0.0	0.3	40.9	0.0	1.0	787.0	0.0	66.2	1455.4	0.0	6160.6	0.0	0.0	2.9	0.0	0.4	16.6	56.0	4.9	264.0	0.4
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969720-92985066	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"GAMG: 10.6;SuSa: 2.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"midbrain: 0.8;pons and medulla: 1.2"	HPA074024	Supported					NA	NA					"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.1	0.0	0.3	0.0	3.0	0.0	0.0	0.1	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1		0.0	0.0	0.0	0.0	4.5		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0			0.0		1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYL10	"MGC3479, MYLC2PL, PLRLC"	ENSG00000106436	"Myosin light chain 10"	Q9BUA6	7	101613325-101629296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.5;skeletal muscle: 9.1"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 1.4;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"PC-3: 12.3;RH-30: 7.1;SuSa: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019763	Uncertain		Uncertain	Microtubules		NA	NA			Microtubules		"HPA019763: AB_1854243"		"unprognostic (2.32e-2)"		"unprognostic (3.09e-1)"					"unprognostic (1.11e-1)"		"unprognostic (1.74e-2)"	"unprognostic (2.78e-3)"		"unprognostic (5.04e-3)"	"unprognostic (8.93e-2)"		"unprognostic (1.10e-2)"	0.2	0.1	0.2	0.2	0.2	1.5	0.2	0.2	0.3	1.9	0.2	0.2	0.2	0.1	0.9	0.4	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	2.7	2.0	0.2	2.9	0.9	0.2	0.3	0.2	9.1	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.2	0.2	0.2	2.9	0.6	1.0	0.2	1.4	1.0	4.5	0.9	1.4	1.3	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.0	0.3	0.1	0.5	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.8	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.3	0.0	12.3	0.0	7.1	0.0	0.1	0.5	0.2	0.0	0.1	0.1	1.2	3.7	0.2	0.1	0.3	0.6	1.3	0.0	0.2	0.4	0.2	1.2	0.1	0.3	0.0	4.5	0.9	0.8	0.4	0.5	0.4	0.9	0.6	0.8	0.3	1.4	0.9	0.7	3.4	1.4	0.5	1.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	822	"heart muscle: 639.9"	"Cell type enriched"	"Detected in single"	8987	"Cardiomyocytes: 8328.0"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"BEWO: 14.8;CACO-2: 50.4;SuSa: 20.8"	"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced					NA	NA					"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	639.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.1	0.0	50.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.0	20.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8328.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"		15	35084193-35085110	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 1.5;skin 1: 1.7;testis: 2.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"					"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	85	"NTERA-2: 32.7;SuSa: 15.4"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.0	0.0		0.0		0.1	0.6		0.0	0.0	0.0			0.4	0.0	1.1	0.0	0.0	0.2	0.0			0.0	0.0	0.2	0.0			0.2	0.0	0.8		0.0		0.3	0.1		0.0	0.2	0.0	1.7	0.0	0.1		0.0	0.0	2.3			0.0		0.0	0.1		0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4, X-linked"	Q8N0W4	X	5840637-6228863	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 19.4;Cone photoreceptor cells: 23.6;Leydig cells: 16.7;Melanocytes: 13.5;Peritubular cells: 28.0;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 1.5"	"Group enriched"	"Detected in some"	4	"AF22: 29.3;NTERA-2: 23.2;SuSa: 23.7"									HPA001651	Approved					NA	NA					"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	4.9	2.3	8.3	2.8	10.7	0.3	3.4	12.2	19.2	8.2	3.6	3.7	0.4	2.1	3.7	1.0	1.3	3.4	4.0	5.4	7.9	9.9	0.8	2.2	1.9	1.7	5.6	6.4	16.8	0.9	12.3	2.6	5.4	5.7	2.0	3.2	2.1	1.5	3.3	0.7	1.2	2.9	5.6	4.3	3.2	1.9	3.9	3.9	56.3	1.0	0.0	1.1	3.6	1.8	1.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	3.7	0.0	23.2	0.0	0.0	0.0	0.0	0.0	2.1	5.9	1.4	1.8	0.0	0.0	0.0	23.7	3.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	10.7	12.2	14.7	7.9	9.9	5.6	6.4	5.7	3.9	0.0	0.3	0.0	0.1	0.2	19.4	2.7	0.0	1.4	0.0	0.0	23.6	3.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.3	0.2	16.7	0.0	13.5	0.0	0.0	10.3	0.0	0.0	28.0	0.0	3.0	12.9	0.7	1.6	4.9	0.5	3.0	0.0	0.0	0.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell type enhanced"	"Detected in single"	32	"Horizontal cells: 3.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.0	1.5	0.0	0.0	9.3	0.5	0.0	0.0	0.1	7.9	15.2	0.1	0.0	0.2	11.2	0.1	0.3	0.1	0.8	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 37.6"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BEWO: 31.7;NTERA-2: 114.0;SuSa: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	7.9	10.0	23.5	12.1	27.7	4.4	9.6	37.1	20.7	15.0	11.9	10.6	19.9	4.9	23.3	11.1	12.6	18.4	12.2	11.0	18.4	10.2	11.0	3.0	10.8	11.1	9.8	20.6	23.5	10.2	26.2	34.5	10.3	13.9	14.2	7.1	18.3	15.5	16.3	8.0	4.0	8.2	17.1	9.1	9.9	9.2	26.5	12.3	7.8	18.9	5.5	10.5	11.5	13.5	2.4	2.9	1.5	5.9	2.1	3.8	1.9	1.4	2.7	10.5	9.6	3.0	3.3	31.7	1.4	3.0	2.6	3.4	1.4	2.3	3.7	1.2	2.4	3.8	1.1	2.8	3.4	3.2	12.3	1.6	4.9	2.6	1.6	3.5	2.4	8.4	4.1	2.1	4.2	4.1	7.9	3.0	4.2	0.9	1.3	2.7	1.6	3.5	4.2	114.0	0.5	0.7	5.1	6.7	0.1	2.6	5.5	1.9	6.9	2.2	5.2	3.7	41.2	0.7	2.5	1.8	4.4	7.5	3.0	2.0	2.6	1.6	5.3	2.1	1.3	3.1	1.5	0.5	0.0	2.1	2.5	1.3	2.4	3.5	3.8	0.3	2.4	3.1	2.5	0.1	2.1	5.9	2.9	1.9	1.9	23.5	27.7	37.1	20.7	18.4	10.2	9.8	20.6	13.9	12.3	14.9	20.3	1.7	4.9	2.2	21.8	0.4	10.2	20.1	20.5	8.7	25.5	4.9	1.7	4.7	19.5	9.0	0.5	0.0	4.5	9.0	6.9	5.1	18.5	1.7	3.8	15.9	10.9	7.4	2.5	14.4	13.3	3.4	6.8	1.8	2.2	16.3	4.7	2.3	11.3	4.7	37.6	0.0	6.6	13.5	23.0	2.0	4.2	6.9	1.1	4.1
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 262.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	13.3	8.0	0.0	3.4	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	14.2	0.0	75.1	0.3	2.4	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.1	0.0	0.0	96.0	0.0	65.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1	6.0	18.3	0.0	1.4	262.6	0.0	19.4	0.0	9.4	33.0	0.0	0.0	1.5	0.0	0.0	0.4	27.7	0.0	0.0	0.0	0.2	42.9	0.3	3.5	0.0	3.2	0.0	0.0	16.5	0.0	0.2	6.1	0.2	28.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	62.4	1.1	0.2	42.3	2.9	0.0	0.0	0.0
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 15.3;Collecting duct cells: 8.7;Enterocytes: 8.4;Pancreatic endocrine cells: 8.5"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HAP1: 49.8;NTERA-2: 132.5;SuSa: 87.3"									"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.2	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	2.3	2.3	1.2	1.2	4.9	3.1	5.7	1.2	5.2	4.3	1.2	1.2	0.0	11.1	5.0	2.0	1.2	1.2	1.2	1.2	8.8	0.0	1.2	1.2	1.2	4.7	1.0	1.2	1.2	3.0	1.2	1.8	5.9	1.2	1.2	1.2	6.3	2.2	1.2	1.2	1.2	1.2	1.2	11.2	1.2	3.0	1.8	1.8	1.0	1.1	0.9	0.3	0.5	0.2	7.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.6	49.8	0.6	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	132.5	0.2	0.0	0.1	0.1	0.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	87.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	1.4	1.0	0.5	0.8	0.7	0.5	1.0	0.4	0.4	0.2	3.0	0.9	0.6	1.8	1.1	0.5	1.8	0.3	0.3	1.2	1.2	1.2	1.2	1.2	0.0	1.2	1.2	1.2	1.2	0.0	1.4	0.5	2.4	4.6	0.7	0.4	15.3	1.4	1.2	8.7	2.0	0.0	0.0	4.8	0.0	0.7	8.4	0.0	5.8	0.1	0.5	3.6	0.0	1.5	0.1	0.0	1.2	0.6	0.0	0.0	0.0	0.8	1.7	1.0	3.1	0.0	8.5	3.7	0.7	2.1	0.9	0.0	1.2	0.0	0.4	3.3	0.1	0.0	2.9	3.8
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"NTERA-2: 33.7;SuSa: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.4	1.1	0.2	0.3	0.2	1.1	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	0.2	0.1	1.7	0.3	0.2	0.4	1.2	0.2	0.2	0.2	0.6	0.3	5.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.6	1.0	1.4	1.6	1.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	9.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.6	1.0	0.4	0.8	1.4	1.1	0.7	0.3	1.6	2.5	1.9	1.4	1.0	1.6	1.0	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.7	0.5	0.5	7.6	1.0	0.2	0.2	0.0	0.2	1.2	0.7	11.5	0.2	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	2.1	0.1	0.4	0.3	0.5	1.4	0.1	0.2	0.5	0.5	0.3	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	5.6	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3	0.0	8.0	0.5	0.9	16.3	2.9	4.3	0.0	2.7	1.2	0.0	2.0	0.0	0.0	0.0	0.6	10.9	0.0	0.0	0.0	0.1	65.7	0.5	4.7	0.0	0.3	1.6	0.0	30.7	0.0	2.3	93.2	1.9	182.2	0.0	0.0	156.5	0.0	0.0	187.7	0.0	4.7	25.8	26.8	2.7	0.8	8.7	0.2	0.0	0.0	0.7
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Group enriched"	"Detected in some"	7	"AF22: 47.4;SuSa: 57.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.0	47.4	1.0	0.0	0.0	4.8	0.4	1.4	1.2	1.7	7.9	0.2	0.0	2.0	0.0	1.8	0.0	0.1	0.1	1.7	0.0	2.5	0.3	0.3	3.0	0.3	0.3	0.0	0.1	0.0	0.5	0.8	0.9	0.8	0.0	0.8	0.0	0.7	0.6	0.0	0.0	1.9	0.0	1.1	0.0	7.5	0.0	0.9	0.1	0.6	2.7	0.4	0.6	2.6	57.9	0.2	0.1	0.0	0.6	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3	8.9	13.2	0.0	0.0	0.2	9.5	4.6	0.0	0.0	4.5	15.7	180.6	18.0	0.0	0.0	13.5	5.3	0.0	0.0	0.2	4.2	1.9	0.1	0.0	0.0	1.5	0.0	0.0	2.5	0.0	18.8	4.9	0.0	0.0	0.0	0.0	2.8	0.4	0.0	2.5	1.1	63.9	0.0	1.0	7.2	13.4	0.0	5.0	0.0	0.0	0.1
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	146	"placenta: 495.8"	"Cell type enriched"	"Detected in some"	171	"Syncytiotrophoblasts: 1321.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"																		0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	495.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.7	0.4	0.1	0.0	0.0	0.0	0.5	0.6	0.6	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.5	6.3	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1321.0	0.0	0.0	0.0
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 34.5"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 74.4;Spermatogonia: 75.5"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.7;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079488			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA079488: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	74.4	75.5	0.0	0.0	0.0	0.0	0.0
RBMXL2	"HNRNPG-T, HNRPGT"	ENSG00000170748	"RNA binding motif protein, X-linked like 2"	O75526	11	7089027-7090900	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	199	"testis: 70.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 111.8;Late spermatids: 105.0;Spermatocytes: 228.1"	"Cancer enriched"	"Detected in single"	133	"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 1.5;HUVEC TERT2: 1.9;SuSa: 2.0"									"HPA038912, HPA051842"	Enhanced					NA	NA					"HPA038912: AB_10670913, HPA051842: AB_2681634"		"unprognostic (3.73e-1)"			"unprognostic (2.24e-1)"							"unprognostic (5.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.77e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	0.0	0.0	228.1	16.2	0.0	0.0	0.0	0.0	0.0
RTP1	"MGC35450, Z3CXXC1"	ENSG00000175077	"Receptor transporter protein 1"	P59025	3	187197486-187201465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;testis: 1.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 1.9;Late spermatids: 1.1;Spermatocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"SuSa: 9.2;T-47d: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (2.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.29e-1)"		"unprognostic (1.91e-1)"				"unprognostic (2.63e-1)"			"unprognostic (2.89e-1)"			0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	5.5	0.0	0.0			0.0	0.0	0.0	0.6	0.0	0.0	0.2	1.3	4.4	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		1.0	0.0		0.0	0.4	0.0	0.0	0.1	0.1	0.8	0.0	0.0	1.9			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 88.6"	"Group enriched"	"Detected in some"	9	"Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 14.6"	"Group enriched"	"Detected in some"	10	"BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA					"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	88.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	14.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Group enriched"	"Detected in some"	4	"Enterocytes: 4.1;Extravillous trophoblasts: 1.7;Kupffer cells: 3.5;Paneth cells: 1.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.1;RPTEC TERT1: 1.1;SuSa: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported				NA	NA					"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 462.0"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"	"Group enriched"	"Detected in many"	5	"BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA		33000000	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.6	2.5	2.4	8.5	143.6	2.3	2.5	2.3	5.4	154.0	1.0	0.1	0.0	1.6	3.2	0.0	0.2	0.3	4.2	4.5	0.1	8.9	0.6	20.2	6.7	3.2	13.0	3.5	0.2	6.1	2.8	5.4	2.1	0.7	4.1	2.1	2.1	0.0	0.2	3.4	29.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.0	113.9	0.0	0.4	2.1	2.9	1.5	5.6	0.2	0.0	6.2	0.4	8.5	1.5	1.5	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5	134.0	147.7	116.7	2.9	115.1	27.9	8.4	7.6	18.7	48.9	3.5	58.9	41.5	0.0	0.2	2.4	227.7	0.0	0.0	0.0	218.4	149.1	3.8	462.0	1.0	97.9	4.8	1.2	85.3	85.8	1.9	9.5	229.2	173.7	1.0	0.0	19.2	0.8	0.2	7.4	1.2	68.8	116.4	236.4	1.4	0.6	71.6	93.1	133.8	0.0	2.8
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.1;OE19: 7.1;SuSa: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain					NA	NA					"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.2	0.4	0.4	0.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0	1.6	1.4	0.2	1.1	0.0	0.3	3.1	0.1	0.0	0.2	0.1	0.2	1.3	1.2	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.3	0.5	0.3	1.4	7.1	0.3	0.5	0.1	0.4	0.2	0.3	0.4	0.4	1.5	0.2	0.0	10.3	0.3	0.1	0.1	0.5	0.4	0.4	0.3	0.8	0.3	0.1	0.2	0.3	0.1	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3	0.0	5.3	0.0	0.4	0.5	0.0	0.8	12.7	0.0	2.3	0.0	0.0	0.0	0.0	10.1	0.5	0.0	2.6	0.0	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.4
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 5.3;Late spermatids: 1.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Group enriched"	"Detected in some"	4	"HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	42.6	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell type enriched"	"Detected in single"	6	"Collecting duct cells: 1.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	34	"HaCaT: 10.2;SuSa: 6.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	20	"Endothelial cells: 1521.8;Peritubular cells: 2372.1;Sertoli cells: 4598.4"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 17.8;SuSa: 25.3;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		660000000			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	102.2	21.9	110.3	18.8	139.9	0.9	52.1	42.9	212.1	123.2	58.0	17.9	23.8	19.7	148.7	74.6	56.4	92.8	74.7	80.9	98.8	40.9	13.2	4.5	58.7	14.6	67.5	106.4	45.2	13.0	15.8	38.3	48.8	69.7	97.0	30.4	7.9	31.5	166.0	35.2	13.1	27.4	185.6	82.5	23.9	40.8	29.2	53.9	1.2	38.8	24.4	15.6	103.9	50.3	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.5	0.0	17.8	0.2	0.1	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.0	1.9	0.0	0.0	1.4	0.0	0.2	0.8	0.3	0.8	0.2	1.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.4	0.1	2.7	0.4	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.6	1.4	0.1	0.1	0.1	25.3	0.3	0.3	0.0	0.2	0.2	1.0	0.1	7.0	0.9	0.4	2.7	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.3	0.0	0.0	110.3	139.9	42.9	136.4	98.8	40.9	67.5	106.4	69.7	53.9	11.9	84.8	13.7	145.4	41.1	7.3	256.0	2.5	13.4	79.6	7.0	2.0	1.7	11.6	0.5	9.5	1521.8	0.0	0.0	0.4	4.4	128.5	36.6	7.0	7.4	8.4	3.2	0.0	459.7	4.1	21.4	610.7	30.6	54.0	0.0	0.0	177.6	0.1	0.0	2372.1	11.0	29.9	4598.4	816.1	4.7	6.6	34.9	2.1	4.9	0.0	107.5
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 10.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Group enriched"	"Detected in some"	12	"EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	9.9	0.1	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.5	0.0	0.0	0.0	10.4	0.0	0.2	3.3	1.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.3	0.0	2.1	2.7	1.6	0.0	1.3	1.2	0.0	0.9	0.8	0.0	0.0	0.0	2.0	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.5	3.0	0.0	0.2	0.0	0.0	0.3
TAC3	"NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 133.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 15.0;SuSa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.5	0.6	3.9	1.5	20.0	0.8	0.5	0.0	11.0	0.5	1.2	0.1	0.0	1.5	0.6	0.5	0.5	0.5	0.6	0.5	4.4	9.5	0.5	0.5	0.5	0.5	0.8	2.1	0.5	0.7	0.5	0.0	133.5	1.5	0.5	1.0	0.3	0.5	0.5	0.5	0.7	3.2	2.0	9.4	0.5	8.1	0.8	0.2	0.0	0.5	0.0	0.6	2.2	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.4	0.0	1.1	0.3	0.0	2.9	0.0	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	15.0	0.4	0.0	0.0	0.0	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	2.5	0.7	0.0	0.9	0.0	15.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.0	0.0	11.0	4.4	9.5	0.8	2.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	15.3	0.0	1.7	0.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"Basal glandular cells: 12.6;Urothelial cells: 38.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	38.8
TNFSF8	"CD153, CD30LG"	ENSG00000106952	"TNF superfamily member 8"	P32971	9	114893343-114930595	"Cancer-related genes, CD markers, Predicted membrane proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.6;lymphoid tissue: 48.1"	"Group enriched"	"Detected in some"	4	"B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Daudi: 34.1;SuSa: 16.1;U-698: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.82e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.58e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.82e-1)"	3.6	1.7	1.1	12.0	1.7	12.7	1.8	0.5	0.9	1.6	2.4	1.4	0.6	0.3	1.1	2.5	1.4	1.5	4.6	2.8	1.1	1.2	1.8	1.4	4.9	48.1	1.6	0.6	0.9	1.1	0.0	0.8	2.2	1.0	1.3	1.9	1.4	3.7	0.9	0.7	1.0	7.0	1.3	2.8	14.9	1.7	1.1	1.0	45.6	1.6	0.8	18.5	3.2	1.3	1.7	7.3	3.9	14.1	1.0	18.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	14.1	0.0	4.1	7.3	13.8	1.0	16.4	9.8	7.3	1.7	18.6	13.5	3.9	1.0	0.9	4.0	5.9	8.7	1.1	1.7	0.5	0.9	1.1	1.2	1.6	0.6	1.0	1.0	0.0	0.0	4.4	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	0.0	0.0	1.3	6.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.2	0.0	0.0
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938846-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 46.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.6;Late spermatids: 4.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	15	"pons and medulla: 46.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 2.9;NTERA-2: 3.1;SCLC-21H: 1.5;SuSa: 1.0"	"Group enriched"	"Detected in some"	32	"midbrain: 127.6;pons and medulla: 36.3"	"Group enriched"	"Detected in some"	10	"midbrain: 95.6;pons and medulla: 91.5"	CAB078198	Enhanced					NA	NA					"CAB078198: AB_2665804"	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.1	0.2	0.4	0.3	0.5	0.1	0.1	0.3	4.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	3.0	1.5	0.1	0.3	0.1	0.1	0.9	0.0	0.1	1.7	0.1	3.2	0.1	46.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.3	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	1.4	3.0	1.5	0.9	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.1
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"	"Group enriched"	"Detected in some"	5	"SuSa: 6.5;U-87 MG: 23.8"									"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6	6.0	31.6	2.7	0.1	0.3	0.0	0.3	2.5	13.4	19.4	0.0	0.0	0.3	0.0	0.3	10.6	0.5	0.0	0.0	0.2	0.9	0.7	0.1	5.8	0.2	25.6	0.0	0.0	1.3	32.3	13.1	0.0	79.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	12.2	0.0	0.0	0.0
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083892-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;testis: 3.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 1.4;SuSa: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038539	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.1	0.0	0.2	0.1	2.5	0.1	0.4	0.7	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	2.5	0.7	0.8	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 1.1;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"AF22: 1.9;SuSa: 5.7"	"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.0	0.3	1.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	5.7	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.0	0.6	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005050	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.7;placenta: 6.6;testis: 7.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 41.4;Extravillous trophoblasts: 49.9"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"BEWO: 47.2;SuSa: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA					"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.5	0.2	0.2	0.3	0.2	1.3	0.2	0.2	0.3	0.3	0.9	0.2	0.2	0.6	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.3	0.4	0.2	1.1	0.8	0.3	0.2	0.2	0.2	0.0	0.2	6.6	1.3	0.2	0.3	0.2	0.4	0.2	1.9	1.8	0.2	0.2	0.2	1.1	0.5	7.1	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.9	1.2	4.7	1.0	2.3	2.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	33.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	4.3	1.0	1.2	2.0	0.8	1.5	1.7	1.6	1.3	0.4	1.9	1.7	1.7	4.7	2.3	0.9	1.2	1.5	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	41.4	0.0	0.0	0.0	0.0	49.9	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	7.9	0.0	0.0	0.1
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672392-29681110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.7;heart muscle: 14.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.2;Extravillous trophoblasts: 3.1;granulocytes: 2.3;Late spermatids: 3.6;Pancreatic endocrine cells: 2.7"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	14	"BEWO: 12.0;SuSa: 3.4"					"Low region specificity"	"Detected in all"			HPA047172	Uncertain					NA	NA					"HPA047172: AB_10960886"	"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.9	0.6	3.8	0.3	4.1	1.1	4.2	0.1	2.3	0.5	0.4	0.4	2.4	0.3	0.5	0.5	0.9	0.3	1.9	14.4	5.5	3.2	0.5	0.3	0.9	6.1	7.6	0.1	0.7	5.2	0.3	0.1	1.5	0.5	0.7	0.6	0.2	2.3	2.1	0.4	0.7	1.2	1.5	12.7	0.8	0.3	1.4	0.1	1.2	0.3	0.7	1.1	1.5	5.5	0.3	0.7	3.8	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.6	0.3	0.3	0.3	0.4	0.5	0.7	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.6	0.3	3.8	4.1	0.1	1.4	5.5	3.2	7.6	0.1	0.5	0.1	0.0	1.1	0.0	0.2	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.9	3.1	0.4	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.0	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.5	0.1	0.2	0.0	0.0	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566142-137577691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.6"	"Cell type enhanced"	"Detected in some"	27	"Muller glia cells: 7.1;Rod photoreceptor cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 2.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Region enriched"	"Detected in all"	8	"cerebellum: 50.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 24.0;NTERA-2: 26.7;SuSa: 16.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.3	0.2	1.4	0.4	2.5	1.1	0.4	50.6	5.8	0.3	0.4	2.7	0.0	0.5	0.5	0.2	0.3	0.3	0.4	0.3	1.9	2.2	0.3	0.3	0.4	0.4	2.4	1.2	0.4	0.5	0.4	1.1	0.4	6.1	0.5	0.3	3.9	0.7	0.3	0.5	0.8	0.5	0.2	1.9	0.5	0.4	3.9	2.2	0.0	0.5	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	16.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	2.5	50.6	2.6	1.9	2.2	2.4	1.2	6.1	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.0
ZNF534	"FLJ25344, KRBO3"	ENSG00000198633	"Zinc finger protein 534"	Q76KX8	19	52429187-52452315	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.8;testis: 8.9"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 3.8;Spermatogonia: 12.0"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"K-562: 1.3;SuSa: 5.2"															NA	NA						"unprognostic (2.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.65e-4)"	"unprognostic (7.25e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.80e-2)"	0.3	0.6	1.5	0.3	3.8	0.0	1.2	3.7	2.5	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.7	0.9	0.3	0.8	1.6	1.6	0.3	0.3	0.5	0.3	0.8	0.3	1.0	0.3	0.0	0.3	0.8	0.3	1.0	0.1	0.3	0.3	0.8	1.4	0.2	0.3	0.3	1.1	0.3	0.1	8.9	0.3	0.3	1.9	2.0	0.3	0.3	0.3	0.2	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.5	0.4	0.1	0.0	0.0	0.0	5.2	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.2	0.2	0.0	0.0	0.1	0.0	1.5	3.8	3.7	1.6	1.6	1.6	0.8	0.3	0.3	0.3	0.0	0.0	0.0	0.7	0.3	0.8	1.4	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.5	0.0	0.4	3.8	12.0	0.4	0.0	0.0	0.0	0.1
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 48.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	11.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.0	8.3	0.0	0.0	0.0	0.0	0.0
ZNF728		ENSG00000269067	"Zinc finger protein 728"	P0DKX0	19	22975468-23003176	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 18.6"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 3.3;Horizontal cells: 7.9;Spermatocytes: 4.2;Spermatogonia: 2.3"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"GAMG: 4.4;SuSa: 4.8;U-266/84: 6.9"															NA	NA						"unprognostic (4.12e-2)"				"unprognostic (4.25e-2)"			"unprognostic (5.00e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-2)"		2.3	1.0	2.7	1.0	6.5	0.4	2.0	1.9	2.9	3.2	1.9	1.3	0.7	0.7	2.8	1.8	1.6	3.4	2.1	3.4	3.8	1.4	2.4	0.7	1.1	0.4	3.2	1.9	5.8	1.0	3.1	5.9	0.8	4.2	2.6	0.9	1.7	1.1	2.6	0.8	0.8	1.1	4.0	3.7	1.3	1.2	18.6	3.6	0.0	4.6	0.1	0.4	3.3	1.4	0.5	0.1	0.1	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	4.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.1	0.5	0.7	0.1	0.1	1.3	0.0	0.0	0.0	0.0	2.7	6.5	1.9	2.9	3.8	1.4	3.2	1.9	4.2	3.6	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.2	2.3	0.0	0.1	0.0	0.0	0.0
